Introduction
Mucins are large, highly O-glycosylated proteins that are present at the surface of most epithelial cells and are involved in the protection and lubrication of the epithelium (Gendler and Spicer 1995) . The expression of mucin genes is organ-and cell-type specific. The increased expression and altered glycosylation of mucins influence cellular growth, differentiation, transformation, adhesion and immune surveillance (Hollingworth and swanson 2004) and are associated with the development of cancer. Mucins have been implicated in the biologic behavior and progression of several cancers. During carcinogenesis, aberrant glycosylation leads to the development of tumor subpopulations with different adhesion properties (Taniguchi et al. 1996; Hiraiwa et al. 1996) . Alterations of mucins during the pathogenesis of cancer have been well documented (Hakomori et al. 2002) . The under glycosylation of mucins results in the creation of tumor associated cryptic carbohydrate core structures Tn, sialyl Tn and T (Taylor-Papadimitriou et al. 1999 ). The Gram-negative bacterium Helicobacter pyroli infects over 50% of the world's population and causes various gastric diseases such as chronic gastritis, peptic ulcer and gastric cancer. Peripheral lymph node addressin (PNAd) containing 6-sulfo sialyl Lewis Xcapped O-glycans on high endothelial venule (HEV)-like vessels are closely associated with pathogenesis of H pyroli-related diseases. The 1,4 GlcNAc-capped O-glycans expressed by gastric gland mucous cell-derived mucin prevents colonization of H pyroli. Thus, the differential expression of distinct O-glycans in stomach provides therapeutic potentialities based on specific carbohydrate modulation (Nakayama et al. 1999; Reis et al. 2000 and Kobayashi et al. 2009 ). Werther et al. (1996) examined the frequency of sialyl Tn expression and its prognostic value in gastric cancer by immunohistochemical analysis of 340 gastric tumors and found that sialyl Tn expression is a marker of gastric cancer progression suggesting that cancer associated mucins play a role in the malignant behavior of the tumor. Santos-Silva et al. (2005) have reported that polymorphism in the MUC1 tandem repeat exerts influence on the expression of cryptic carbohydrate core structures in gastric cancer cells and the aggressive gastric tumors tend to express T antigen. Immunohistochemical study of Amado et al. (1998) for the expression of dimeric sialyl Lewis x in 97 gastric carcinomas revealed a correlation between high expression of dimeric sialyl Lewis x and venous invasion and poor outcome in gastric cancer patients. Petretti et al (1999) studied RNA expression of several glycosyltransferases in surgical specimens of gastric carcinomas and found significant enhancement in the expression of ST3Gal IV and FucT IV. A comprehensive study by Carvalho et al. (1999) on mucin expression in a panel of gastric carcinoma cell lines found no apparent relationship between the mucin core proteins and the simple mucin type or Lewis x carbohydrate antigens that are expressed in each cell line. Thus there exists a complexity in glycosyltransferase activities which lead to several tumorassociated carbohydrate structures in gastric carcinoma. A comparative study of gene-expression profiles of adenocarcinoma metastases and primary adenocarcinomas (Ramaswamy et al. 2003) indicated that a subset of primary tumors resembled metastatic tumors with respect to a gene-expression signature and that solid tumors carrying this gene-expression signature were most likely to be associated with metastasis and poor clinical outcome. These results further suggested that the metastatic potential of human tumors is encoded in the bulk of a primary tumor and thus challenged the notion that metastases arise from rare cells within a primary tumor that have the ability to metastasize (Poste et al. 1980) . Thus, it became obvious that a very consistent change of some biological events in a primary tumor as opposed to the normal tissue has the possibility of being related to the malignant potential of the tumor. Recently, we examined the patterns of glycosyl-and glycan-sulfotransferase activities in several cancer cell lines and the resulting data strongly suggested an association of unique carbohydrate structures with signature potential in individual cancers (Chandrasekaran et al. 2006 ). The present study was aimed to identify the glycosyl-or sulfotransferase which exhibits the most marked and consistent change of activity in gastric tumorigenesis, by comparing the pattern of various glycosyl and glycan: sulfotransferase activities in tumorous and normal gastric tissues of each patient in ten gastric carcinoma cases.
Materials and methods

Tissue specimens
Human gastric tumor specimens were obtained during surgical procedures at Roswell Park Cancer Institute and stored frozen within 1h at -70°C. We studied the gastric tumor as well as non-tumor stomach tissue specimens from the same patient in ten gastric carcinoma cases and, in addition, two gastric tumor specimens in which case normal stomach tissue specimens were unavailable. The Pathology report on the tumors is presented in Table 1 and  Table 4 . When the samples were collected from Pathology, a portion of the sample adjacent to that used for enzyme assay was fixed in formalin and embedded in paraffin. Slides were prepared from the paraffin blocks, and stained with hematoxylin and eosin by standard procedures. A board-certified pathologist studied the slides to determine the distribution of cell types within the tumor tissue compared to the control tissue from the same case (although in three cases non-tumor tissue was not available). Due to the invasiveness of the gastric cancer in these cases, both the tumor and the non-tumor tissue samples generally contained smooth muscle. The smooth muscle component existed at roughly equivalent percentage in the tumor sample and non-tumor control on a case by case basis sometimes being a little larger in either tumor or non-tumor sample. The major difference between the normal and tumor sample in this study was that the tumor contained malignant epithelial cells, and the normal never did. With the exception of case 10, the amount of protein solubilized from the tumor and the corresponding non-tumor specimen by Triton X-100 did not vary much as evident from the values reported in Table 1 . Thus, it becomes evident that a comparison of each glycosyltransferase and glycan:sulfotransferase activity per mg protein of the tissue extract between tumor and the corresponding non-tumor specimen is quite meaningful in understanding the quantitativ e c h a n g e o f e a c h e n z y m e a c t i v i t y i n tumorigenesis. 
Gastric
Acceptor compounds
The synthetic compounds used as acceptors in this study have already been used in our earlier studies (Chandrasekaran et al. 1995; 2006) and, thus, are welldocumented acceptors for measuring the reported enzyme activities.
Processing of tissue specimens
The tissues were homogenized at 4°C with 4 volumes of 0.1 M Tris Maleate pH 7.2, 0.1% NaN 3 using kinematica. After adjusting the concentration of TritonX-100 to 2%, these homogenates were mixed in the cold room for 1h using Speci-Mix (Thermolyne) and then centrifuged at 20,000g for 1h at 4°C. The clear fat-free supernatant was stored frozen at -20°C until use. Aliquots of 10µL from this extract were used in assays run in duplicates.
Enzyme assays
Glycosyltransferase activity in tumor extract was determined by mixing the tumor extracts with acceptor and radiolabeled monosaccharide donor under the reaction conditions detailed below, followed by separation of unreacted donor from the radioactive product using anionic or hydrophobic chromatography. In all cases, the radioactive content of isolated products was determined by using 3a70 scintillation cocktail (research Products International, Mount Prospect, IL) and a Beckman LS9000 scintillation counter. Controls for each assay contained the reaction mixture with everything except the acceptor. Radioactivity of control was subtracted from that of product to obtain the results presented in the Tables. All assays were run in duplicate. Results from duplicate runs did not vary by more than 5%. The following are the conditions for individual enzymatic assays. Reaction temperature in all cases was 37°C.
2.5 Sialyltransferase 2,3-and 2,6 sialyltransferase (ST) assay reactions proceeded for 2h in a mixture containing 100mM sodium cacodylate buffer (pH 6.0), 7.5mM acceptor, CMP-[9-3 H] NeuAc (typically 0.2μCi) and 10μl tumor extract in a total volume of 20μl (Chandrasekaran et al. 1995 (Chandrasekaran et al. , 2005 .
Gal/GalNAc transferases
GlcNAc: 1,4Gal-T and GalNAc: 1,3Gal-T assay mixtures in duplicate contained 0.1M Hepes-NaOH pH 7.0, 7mM ATP, 20mM Mn acetate, 1mM UDP-Gal. UDP [ 14 C] Gal (0.05μCi; 327mCi/mmol; Amersham), 0.5mM acceptor (unless otherwise stated) and 10μl tumor extract in a total volume of 20μL (Chandrasekaran et al. 2001) . It was incubated for 4h; GlcNAc: 1,4GalNAc-T assay mixtures in duplicate contained 0.1M Hepes-NaOH ph7.0, 7mM ATP, 20mM Mn acetate, UDP [ 3 H] GalNAc (0.20μCi; 7.8Ci/mmol: New England Nuclear Corp.) 7.5mM acceptor and incubated for 4h (Chandrasekaran et al. 2001 ).
Fucosyltransferases
1,2, 1,3-, 1,4-fucosyltransferase and FT VI assay reactions were carried out for 2h in a reaction mixture containing 50mM Hepes buffer (pH 7.5), 5mM MnC1 2 , 7mM ATP, 3mM NaN 3 , 3mM synthetic acceptor, 0.05μCi GDP-[ 14 C]Fuc (290mCi/mmol) and 10μl tumor extract in a total volume of 20μl (Chandrasekaran et al. 1996) .
Glycan: sulfotransferases
Sulfotransferase (Sulfo-T) assay reactions took 2h and required a mixture containing 100mM Tris-Maleate (pH 7.2), 5mM Mg Acetate, 5mM ATP, 10mM NaF, 10mM BAL, 7.5mM acceptor, 0.5μCi of [ 35 S]PAPS (specific activity 2.4Ci/mmol) and 10μl of tumor extract in a total volume of 30μl (Chandrasekaran et al. 2004 ).
Chromatographic methods
Dowex-1-Cl or Sep-Pak C18 cartridges were used to isolate radiolabeled product from the reaction mixture. For Gal-T, GalNAc-T and FT assays, the incubation mixture was diluted with 1ml water and passed through a 1ml bed volume of Dowex-1-Cl column (Chandrasekaran et al. 1996 (Chandrasekaran et al. , 2001 ). The column was washed twice with 1ml water. The breakthrough and the water wash contained the [ 14 C]-galactosylated or [ 14 C]-fucosylated products formed with neutral acceptors . 3ml of 0.1M NaCl was used to obtain [ 14 C]-fucosylated products from sialylated acceptors after water elution. For sialyltransferase assays, the radioactive products from benzylglycosides were separated by hydrophobic chromatography on Sep-Pak C18 cartridge (Water, Milford, MA), and elution of the product was done with 3ml methanol (Chandrasekaran et al. 2005; Palcic et al. 1998) . For sulfotransferase assays, elution of the [35S]-sulfated compound from Dowex-1-Cl column could be achieved by 3ml of 0.2M NaCl (Chandrasekaran et al. 2001 ).
Effect of divalent cations on gastric tumor Gal: 3-O-sulfotransferase activity
For seeing the effect of divalent cations on Gal: 3-O-sulfotransferase activity the incubation mixture contained varying concentration (1-50mM) of Mg acetate, Mn acetate or Ca acetate under the standard incubation conditions. Gal3Sulfo-T4 activity was assayed using 3-O-Me Gal 1, 4 GlcNAc 1,6(Gal 1,3)GalNAc -O-Bn as the acceptor. Gal3Sulfo-T2 activity was measured with the acceptor Gal 1, 4 GlcNAc 1, 6(3-O-MeGal 1, 3)GalNAc -O-Bn.
N-Acetylglucosaminltransferase assay
The reaction mixture (30μl) contained 5mM acceptor, 70 mM Hepes-NaOH pH7.0, 7mM GlcNAc 1, 5 lactone, 14mM Mn acetate, 5mM ATP, 2mM NaN 3 , 0.2μCi UDP-[6-3 H] GlcNAc (NEN-Dupont) and 15μl tumor extract and incubated for 4h at 37°C. The radioactive products from benzyl glycosides were separated by hydrophobic chromatography on SepPak C18 cartridge and from allyl glycoside by Biogel P2 column chromatography as described above. 2.14 Lectin-agarose chromatography PNA-agarose (Sigma), ConA-agarose (Sigma) and GSL II-agarose (Vector) columns of 5 ml bed volume were used under conditions as recommended by suppliers.
β N-acetylhexosaminidase treatment
Thin layer chromatography
TLC was carried out on Silica gel GHLF (250 μm scored 20x20cm; Analtech, Newark DE). The solvent systems A [1 propanol/NH 4 OH/H 2 O (12/2/5 V/V)] and B [n-butanol/acetic acid/H 2 O (3/2/1)] were used. The acceptor compounds were located on the plates by spraying with sulfuric acid in ethanol and heating at 100°C. The radioactive products were located by scraping 0.5cm width segments of silica gel and soaking them in 2 ml water in vials followed by liquid scintillation counting.
Results
Non-reducing terminal of complex carbohydrate chains
Several glycosyltransferases and glycan-sulfotransferases act on the non-reducing terminal of mucin Core2 tetra-and tri-saccharides and Globo backbone unit of gangliosides, core 1 disaccharide and Asparagine linked complex carbohydrate chains terminating in Gal residues, leading to a complexity of cancer-associated terminal glycan structures as shown in Table 2 . Hence, we examined the levels of many of these enzyme activities in gastric tumor tissue as well as non-tumor gastric tissue of the same patient in ten gastric cancer cases for identifying any significant consistent change in any of these enzyme activities in gastric cancer. The specific acceptor compounds used in the present study for assaying the enzymes are reported in Table 3 . The results on various enzyme levels are presented in Tables 4 and 5.
Carbohydrate chain terminal
Modifying glycosyl-and sulfotransferases Table 2 . Glycosyl-and sulfo-transferases involved in carbohydride chain terminal modification 3.2 Fucosyltransferase activities in gastric carcinoma 1,3-FT contributed the major FT activity in both normal and tumor specimens in all cases. In nine cases, the tumor specimens as compared to normal (with the exception case 10) contained lower 1,3-FT activity (a decrease of 10-60%). There was a marked reduction (40-90%) of 1, 2-FT activity in seven cancer cases (2, 3, 4, 5, 6, 7 and 9) . Thus, it is interesting to note that a decrease of 1, 3-and 1, 2-FT activities occurred in the same specimens. On the other hand, 1,4-FT activity and FTVI activity were present in increased level in the same five cancer cases (1, 3, 4, 7 and 10) and in decreased level in the same five cases (2, 5, 6, 8 and 9) . Four tumor specimens (cases 7, 4, 1 and 10) which include two Signet ring cell CA and two mucin producing adenocarcinoma exhibited high elevation of FTVI activity (8.9, 10.5, 51.4 and 199.5 fold respectively) as compared to the corresponding normal specimen. Further, a highly noteworthy finding is that the gastrointestinal stromal tumor specimen (case 12) was distinct in having a low level of 1, 3-FT activity and negligible amounts of 1, 4-FT, 1,2-FT and FTVI activities as compared to other tumor specimens. Table 3 . Specific acceptors for measuring Glycosyl-and Sulfo-transferase activities in gastric tumor and non-tumor specimens 3.3 Sialyltransferase activities in gastric carcinoma ST3 (O) activity, which forms 3'-sialyl T hapten (NeuAc 2, 3Gal 1, 3GalNAc ) was the predominant sialyltransferase activity in all gastric tissue specimens. This activity increased (1.7-172.0 fold) in six (cases 2, 3, 4, 6, 9 and 10) and decreased in four (cases 1, 5, 7 and 8) gastric tissue specimens. ST6(N) activity synthesizing 6'-LacNAc type 2 unit (NeuAc 2,6Gal 1,4GlcNAc -) ranged 4% -78% of the ST3(O) activity in the tumor tissue specimens studied and ST3(N) activity forming 3'-sialyl LacNAc was even far less than ST6(N) activity. Three out of four tumor specimens from Signet ring cell carcinoma (cases 2, 3 and 4) and three out of five tumor specimens from adenocarcinoma (cases 6, 9 and 10) showed an increased level of ST3 (O) activity. Two cases of Signet ring cell CA (1 and 3) and three cases of adinocarcinoma (7, 8 and 9) showed significant ST6 (N) activity in the range 8.2 -78.0% of ST3 (O) activity.
3.4 β-GlcNAc : β1,4-Gal/GalNAc and α-GalNAc : β1,3-Gal transferase activities in gastric carcinoma Three tumor specimens (cases 3, 4 and 10) while exhibiting an increase in 1, 4Gal-T activity, other tumor specimens contained lower level of this activity than the corresponding normal specimens. Six tumor specimens (cases 3, 4, 5, 6, 8 and 10) showed an increased level of 1, 4GalNAc-T activity. It is remarkable that two tumor specimens (cases 5 and 6) from adenocarcinoma contained only 30% and 40% level of -GalNAc: 1, 3Gal-T activity as compared to the normal specimens. On the contrary, the tumor specimen of case 10 as compared to other tumor specimens had a high level of this activity, which exceeded even the levels of its 1, 4Gal/GalNAc-T activities. The level of GalNAc : 1,3Gal-T activity was also higher than 1,4Gal/GalNAc-T activity in Litinis Plastica specimen (case 11) Table 5 . The levels of sulfotransferase activities in human gastric non-tumor and tumor specimens
Glycan: Sulfotransferase activities in gastric carcinoma
Both Gal3Sulfo-T 4 activity specific for Gal 1, 3GalNAc -and Gal3Sulfo-T 2 activity utilizing mainly Gal 1,4GlcNAc -were found, respectively, at 2.4→61.7 fold and 1.7→156.7 fold elevated level in all the gastric tumor specimens studied. On the other hand, an increased level of GlcNAc6-Sulfo-T activity was also evident but to a lesser extent in nine gastric tumor specimens. Five tumor specimens, all from adinocarcinoma (cases 5, 6 7, 9 and 10)
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The identity of Gal: 3-O-Sulfo transferases in human gastric tumor specimens
Acceptor specificities: A consistent marked elevated Gal: 3-O-Sulfotransferase activities in gastric tumors prompted us to establish further the identity of these enzymes with the known cloned Gal3Sulfotransferases (Chandrasekaran et. al. 2004 ). We studied four tumor specimens (cases 2, 3, 6 and 7) for acceptor specificities and the results are presented in Table 6 .
Table 6. Establishing the identity of Gal : 3-O-Sulfotransferases in Human Gastric Tumor Specimens
The values in parentheses are the actual CPM designated as 100% for the acceptor Gal 1, 3GalNAc -O-Al in the cases 6 and 7 and for the acceptor Gal 1,4GlcNAc in the cases of 2 and 3 Gal3Sulfo-Ts of tumor specimens from cases 2 and 3 showed low activity towards Gal 1, 3GalNAc -O-Al and that from cases 6 and 7 very low activity towards Gal 1, 4GlclNAc. Tumor specimens 6 and 7 contained mostly Gal3Sulfo-T 4 (Chandrasekaran et. al. 2004 ). Gal3Sulfo-Ts of tumor specimens 2 and 3 were found to be less active towards Fetuin triantennary asialo glycopeptides, which was established as the best acceptor in our earlier studies for Gal3Sulfo-T 3 (Chandrasekaran et. al. 2004 ). Further, the above enzymes were very active towards Gal 1, 3GalNAc 1, 3Gal -O-Me whereas Gal3Sulfo-T 3 showed very low activity towards this acceptor. Gal3Sulfo-Ts of tumor specimens 2 and 3 were found to have the identity of cloned Gal3Sulfo-T 2 (Chandrasekaran et. al. 2004) . Influence of divalent metal ions (see Fig 1) : None of the divalent metal ions Ca 2+ , Mn 2+ and Mg 2+ had any significant stimulating effect on Gal3Sulfo-T of tumor specimen 7. In fact, a gradual decline in enzyme activity was noticed upon increasing the concentration of Mn 2+ in the reaction mixture. Thus, this enzyme resembled Gal3Sulfotransferase from breast tumor (Chandrasekaran et. al. 1997 ) as well as the cloned Gal3Sulfo-T 4 (Chandrasekaran et. al. 2004 ). On the other hand, the metal ions Ca 2+ , Mn 2+ and Mg 2+ stimulated the activity of tumor specimen 3. Mn 2+ stimulated the activity between 5-20mM and then the activity decreased reaching the initial level at 50mM. This pattern of influence by Mn 2+ on the activity was quite similar to that of Gal3Sulfotransferase from colon tissue (Chandrasekaran et. al. 1997 ) and cloned Gal3Sulfo-T 2 (Chandrasekaran et. al. 2004 ). On the contrary, the activity of cloned Gal3Sulfo-T 3 was stimulated by Mn 2+ reaching the maximum at 40-50mM (Chandrasekaran et. al. 2004 ). Thus, Gal3Sulfo-T of tumor specimen 7 was similar to GalSuflo-T 4 and that of tumor specimen 3 closely resembled Gal3Sulfo-T 2. 
Identification of human gastric tissue α-GlcNAc transferase acting on terminal GlcNAc residue
The present investigation identified two N-acetylglucosaminyltransferase activities in gastric tissues using mucin core 2 tri-and tetra-saccharides as acceptors as reported in Table  7 . An increased level (1.5-8.5 fold) of GlcNAc transferase activity on mucin core 2 tetrasaccharide was observed in three gastric tumor specimens as compared to that of the corresponding non-tumor specimens. Further, the level of this enzyme is about two-fold as compared to the corresponding activity of the other enzyme. The linkages of [6-3 H] GlcNAc residues attached to mucin core 2 tri-and tetra-saccharides were further examined by utilizing TLC and lectin-agarose chromatography techniques (see sections 3.8 and 3.9). Table 7 . The levels of human gastric tissue N-Acetylglucosaminyltransferase activities towards mucin core 2 tri-and tetra-saccharides 
Lectin-agarose chromatography
The primary sugar specificity of PNA is Gal linked 1, 3to GalNAc. ConA binds Man and Glc and GSL II binds terminal GlcNAc but these lectins have additional structural requirements for binding. 1, 3 Galactosidase treatment was subjected to PNA-agarose affinity chromatography and it showed > 90% non-binding to this column. On the contrary to these results, Nakayama et al. (1999) without showing data just mentioned in their paper that their cloned human 1, 4 Nacetylglucosaminyltransferase acted only on the Gal moiety of mucin core 2 trisaccharide. We find that [6-3 H] GlcNAc linkage to 1, 6 linked GlcNAc in mucin core 2 is completely resistant to Jack bean -N-acetyl hexosaminidase which has a broad specificity cleaving nonreducing terminal 1-2, 3, 4 or 6 linked GlcNAc and GalNAc residues (Li and Li 1970 ). This enzyme was also able to cleave very efficiently GlcNAc linked 1, 4 to GlcNAc (N, Nʹ-Diacetylchitobiose) (Li and Li 1970) . Thus GlcNAc transferred to 1, 6 linked GlcNAc has been found to be in -linkage. Nakayama et al. (1999) reported that 1, 4 GlcNAc-T was responsible for the formation of GlcNAc 1, 4 Gal -R which in turn was responsible for class III mucin ConA reactivity. In this connection, it is noteworthy that the present study found that the radioactive compound [6-3 H] GlcNAc GlcNAc 1, 6 (Gal 1, 3) GalNAc -O-Al did not bind to ConA-agarose as well as GSL II-agarose (Fig 4 A and B) . After the removal of Gal by recombinant 1, 3 galactosidase treatment, the resulting radioactive compound still did not bind to GSL II-agarose (Fig 4 C) . 
Discussion
Many risk factors have been associated with the development of gastric cancer, and the pathogenesis is most likely multifactorial. One postulation on the development of this disease involves a succession of histologic changes that commence with atrophic gastritis, advance to mucosal metaplasia, and eventually result in a malignancy (Layke et al. 2004) . Tumor development and growth can be viewed as uncontrolled tissue growth. Tumor growth relies on blood supply by the blood vessels (Kobayashi et al. 2003) . It has been known that a growing tumor secretes factors that induce blood vessel growth (i.e., neovascularization) to support its own growth and survival (Folkman et al. 1995) . A primary cell type of the blood vessels, especially microvessels in a tumor, is an endothelial cell. Therefore, focus has been to discover factors that specifically control endothelial cell proliferation (Davis et al. 2003) . The roles of other factors are just beginning to be understood (Sogn et al. 2005) . The tumor microenvironment needs to be completely characterized for understanding its role in tumor progression and metastasis (Sogn et al. 2005) . Glycoproteins play a role in pathological processes due to immunological response to the altered oligosaccharides (Fukuda et al. 1996) . They have roles in cell adhesion during inflammation and metastasis (Fukuda et al. 1996) . Hence it is anticipated that glycoproteins may have a definite role in tumor microenvironment. Recently an important role for galectins in cancer micrometastasis became evident from the report of Khaldoyandidi, et al. (2003) that interactions between T-antigen of breast cancer cells and galectin-3 mediate both homotypic and heterotypic intercellular adhesion of metastatic breast cancer cells under conditions of flow in vitro and in vivo. A substitution of sulfate at C-3 position of -galactosyl residue in T-hapten enhanced its binding efficiency about 15 fold towards galectin-4 and 3 fold towards galectin-3 (Ideo et al. 2002) . Similarly, the studies of our laboratory on galectin specificities showed that 3-O-Sulfo Gal 1, 4GlcNAc as compared to Gal 1, 4GlcNAc was 3 fold more efficient in binding to galectin-1 (Allen et al. 1998) . Thus, the enhancement of the binding ability to galectins by 3-O-Sulfation ofgalactosyl residues appears to be a common characteristic of galectin family. In addition, 3'-sialylation Core1 in contrast to 3'-sulfated Core1 had very weak affinity for galectin-4 (Ideo et al. 2002) . Hippo et al. (2001) analyzed six gastric cancer cell lines by Northern Blot and observed an up-regulation of galectin-4. Sulfatide was found as a major acidic glycolipid in human gastric mucosa (Natomi et al. 1993 ) and the expression of cerebroside sulfotransferase mRNA in endoscopic bioptic specimens of eleven gastric cancer cases was reported by Kobayashi et al. (1999) . The present study finds several fold consistent increase in Gal3Sulfotransferase activity in gastric tumor. The resulting 3-O-Sulfogalactosyl residues in gastric tumor cell glycoproteins and glycolipids may facilitate the interaction of gastric tumor cells with galectin-4, resulting in intercellular homotypic and heterotypic adhesion of gastric cancer cells.
Conclusion
It becomes evident from the present study that among the various transferases, which can modify the terminal Gal residues in carbohydrate chains as shown in Table 2 , only Gal3Sulfotransferases show a consistent several fold elevated activity in all gastric tumor specimens: Gal3-sulfo-T 4 (Gal3-sulfortransferase specific for Gal 1,3GalNAc -O-Ser/Thr) and GlcNAc6-Sulfo-T are apparently associated with poorly differentiated gastric adenocarcinoma whereas poorly differentiated Signet ring cell gastric carcinoma expresses a high level of Gal3Sulfo-T 2 , a Gal3Sulfotransferase acting on Gal 1,4GlcNAc -terminal unit. The most consistent change in glycosyltransferase activity could be found only with 1, 2-FT. A significant decrease in this activity was seen in the range 40 -90% in seven gastric tumor specimens. Thus, the present study was able to show that down regulation of 1,2-FT activity accompanied by induction of Gal3-O-Sulfotransferase activities acting on Gal terminals could be involved in the facile sulfation of carbohydrate chains, which may contribute to the microenvironment suitable for interaction with galectin-4 in promoting tumor growth and metastasis. Furthermore, the sulfation of Gal terminal as well as GlcNAc residues would render the carbohydrate chains strong anionic charge, resistance to degradation by sialidases, galactosidases and hexosaminidases and this would increase their half-life in receptor-mediated glycoprotein clearance.
